These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12024699)

  • 1. Current methods of colorectal cancer screening.
    Willis MS; Fuda FS; Chenault CB
    MLO Med Lab Obs; 2002 May; 34(5):12-6, 19; quiz 20-1. PubMed ID: 12024699
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening with a fecal multitarget DNA test.
    Young GP; Worthley DL
    Gastroenterology; 2005 Aug; 129(2):757-9; discussion 759. PubMed ID: 16083732
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel molecular screening approaches in colorectal cancer.
    Miller S; Steele S
    J Surg Oncol; 2012 Apr; 105(5):459-67. PubMed ID: 22441897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stool DNA: a viable option for colorectal cancer screening.
    Hardison DM; Shuber AP
    Gastroenterology; 2005 Dec; 129(6):2128-9; author reply 2129. PubMed ID: 16344091
    [No Abstract]   [Full Text] [Related]  

  • 5. Patient perceptions of stool-based DNA testing for colorectal cancer screening.
    Schroy PC; Heeren TC
    Am J Prev Med; 2005 Feb; 28(2):208-14. PubMed ID: 15710277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA bar code: screening methods of colorectal cancer.
    McCudden C; Willis MS
    MLO Med Lab Obs; 2006 Nov; 38(11):10, 12, 14-5 passim; quiz 22-3. PubMed ID: 17225674
    [No Abstract]   [Full Text] [Related]  

  • 7. Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.
    Takai T; Kanaoka S; Yoshida K; Hamaya Y; Ikuma M; Miura N; Sugimura H; Kajimura M; Hishida A
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1888-93. PubMed ID: 19505922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is fecal DNA testing superior to fecal occult-blood testing for colorectal cancer screening?
    Capellá G
    Nat Clin Pract Oncol; 2005 May; 2(5):234-5. PubMed ID: 16264954
    [No Abstract]   [Full Text] [Related]  

  • 9. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleic acids from intact epithelial cells as a target for stool-based molecular diagnosis of colorectal cancer.
    Spethmann S; Fischer C; Wagener C; Streichert T; Tschentscher P
    Int J Mol Med; 2004 Mar; 13(3):451-4. PubMed ID: 14767578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The place of fecal occult blood test in colorectal cancer screening in 2006: the U.S. perspective.
    Bond JH
    Am J Gastroenterol; 2006 Feb; 101(2):219-21. PubMed ID: 16454821
    [No Abstract]   [Full Text] [Related]  

  • 13. [Colorectal cancer screening: immunological test for faecal occult blood preferred].
    Jansen JB; van Rossum LG; Laheij RJ
    Ned Tijdschr Geneeskd; 2009; 153():A474. PubMed ID: 19785842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fecal methylated DNA for the detection of colorectal cancer].
    von Delius S; Jung A; Schmid RM
    Z Gastroenterol; 2006 Sep; 44(9):1001-2. PubMed ID: 16981074
    [No Abstract]   [Full Text] [Related]  

  • 16. New method for colorectal cancer diagnosis based on SSCP analysis of DNA from exfoliated colonocytes in naturally evacuated feces.
    Onouchi S; Matsushita H; Moriya Y; Akasu T; Fujita S; Yamamoto S; Hasegawa H; Kitagawa Y; Matsumura Y
    Anticancer Res; 2008; 28(1A):145-50. PubMed ID: 18383838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Offering patients colorectal cancer screening.
    Church TR
    J Natl Cancer Inst; 2005 Mar; 97(5):328-9. PubMed ID: 15741562
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for colorectal cancer--now and the near future.
    Bromer MQ; Weinberg DS
    Semin Oncol; 2005 Feb; 32(1):3-10. PubMed ID: 15726501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation stool DNA testing: expanding the scope.
    Ahlquist DA
    Gastroenterology; 2009 Jun; 136(7):2068-73. PubMed ID: 19379748
    [No Abstract]   [Full Text] [Related]  

  • 20. Stool test for colorectal cancer screening: what is going on?
    Bonanno E; Rulli F; Galatà G; Pucci S; Sesti F; Farinon AM; Spagnoli LG
    Surg Oncol; 2007 Dec; 16 Suppl 1():S43-5. PubMed ID: 18055195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.